(1 - 13 von 21
)
Novel Bcl-2 inhibitor BGB with excellent potency for both wild ...www.morressier.com › event › article
www.morressier.com
... Aiying Xu. Zhijun Zheng. Junhua Liu. Zhenzhen Cheng. Haimei Xing. Yuan Hong. Xuebing Sun. Yin Guo. Haipeng Xu. Changyou Zhou. Xuesong Liu. Lai Wang. Zhiwei Wang.
| NDAQ:BGNE | Press Release | Beigene Stockhousestockhouse.com › news › press-releases ›
stockhouse.com
· ... Aiying Xu, Zhenzhen Cheng, Haimei Xing, Zhiwei Wang, Xuesong Liu, Lai Wang; Abstract 3077: Preclinical characterization of BGB , a ...
[PDF] 業務發展最新情況百濟神州於2023年ASCO年會上公佈管file.finance.sina.com.cn › hk_realtime_announcement › news
file.finance.sina.com.cn
· Sun, Yuan Hong, Yutong Zhu, Aiying Xu, Zhenzhen Cheng, Haimei Xing, Zhiwei. Wang, Xuesong Liu, Lai Wang; Abstract 3077: Preclinical ...
百济神州于2023年ASCO年会上公布管线进展,继续强化其抗肿瘤 ...www.pharmnews.com › news › articleView
www.pharmnews.com
· ... Aiying Xu, Zhenzhen Cheng, Haimei Xing, Zhiwei Wang, Xuesong Liu, Lai Wang; Abstract 3077: Preclinical characterization of BGB , a ...
sortiert nach Relevanz / Datum